- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
17
Companies with a Value score of at least 3, ordered by Value score
17 companies
Gilead Sciences
Market Cap: AR$181.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$58,600.00
7D
7.8%
1Y
50.4%
Bristol-Myers Squibb
Market Cap: US$136.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$23.30
7D
6.1%
1Y
n/a
Bristol-Myers Squibb
Market Cap: AR$136.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$35,800.00
7D
6.9%
1Y
67.7%
Bayer
Market Cap: AR$47.6b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$28,520.00
7D
-7.5%
1Y
n/a
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$7.04
7D
4.3%
1Y
n/a
GSK
Market Cap: US$75.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.34
7D
3.7%
1Y
33.4%
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,740.00
7D
5.0%
1Y
n/a
Gilead Sciences
Market Cap: US$181.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$36.76
7D
5.3%
1Y
26.8%
GSK
Market Cap: AR$75.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,690.00
7D
5.9%
1Y
53.5%
Biogen
Market Cap: AR$32.0b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$26,860.00
7D
5.9%
1Y
88.5%
AstraZeneca
Market Cap: AR$187.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$66,800.00
7D
8.5%
1Y
22.9%
Biogen
Market Cap: US$32.0b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$17.42
7D
3.6%
1Y
64.3%
Vertex Pharmaceuticals
Market Cap: AR$138.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,660.00
7D
10.2%
1Y
65.0%
Novartis
Market Cap: US$242.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$41.01
7D
4.0%
1Y
28.4%
Novartis
Market Cap: AR$240.9b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$63,350.00
7D
6.6%
1Y
48.8%
Vertex Pharmaceuticals
Market Cap: US$138.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.67
7D
8.0%
1Y
n/a
AstraZeneca
Market Cap: US$187.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$43.30
7D
6.7%
1Y
8.4%